
    
      The objective of this study is to evaluate the safety and effectiveness of the MobiusHD
      System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal
      study. Patients with resistant hypertension who remain uncontrolled despite pharmacologic
      treatment with maximum tolerated, guideline-directed anti-hypertensive pharmacologic therapy
      will be evaluated.
    
  